Navigation Links
Researchers led by Penn vet uncover the delicate protein balance behind the immune system response
Date:12/10/2007

PHILADELPHIA - A team of researchers from the University of Pennsylvania School of Veterinary Medicine has identified the protein interactions involved in the immune system process that fights infection yet, in certain inflammatory diseases, runs amok and attacks friendly tissue.

The Penn team, led by Christopher Hunter, chair of the Department of Pathobiology at Penn Vet, has identified the pathways that lead to the production of the signaling protein, or cytokine, Interleukin 10 (IL-10) which plays an important role in regulating the balance between the protective white blood, or T, cell response and one that is pathological and out of control.

While IL-10 has long been recognized as a major anti-inflammatory factor, the events that lead to its production have been poorly understood. According to the researchers findings, messenger proteins Interleukin 27, or a combination of Interleukin 6 and another type of messenger molecule called transforming growth factor beta, induce production of IL-10. These results suggest that modulating these messenger molecules could increase IL-10 concentrations that temper overactive immune responses.

This information sheds new light on the immune-system response and may provide directed means to intervene in severe autoimmune diseases such as colitis, multiple sclerosis and arthritis.

The deeper we delve into the role of cytokines in the immune system response, the more we realize that they are part of an elaborately balanced system kept in check by the conflicting regulatory functions of the cytokines themselves, Hunter said. When combined with the work from our colleagues at Schering Plough, Harvard and Jefferson University, these studies provide new insights into the pathways that can be used to temper autoimmune inflammation.

Although there are many sources of IL-10 in the body, the details of how it is synthesized were poorly understood. Hunters team determined that the process begins with c
'/>"/>

Contact: Jordan Reese
jreese@upenn.edu
215-573-6604
University of Pennsylvania
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, Antibiotic Resistance and Antibiotic Tech...linker.com/p0166825/Antibiotic-Resistance-and-Anti...vide an in-depth review of the global market for a... ,, Offer an analysis of antibiotics resistance...
(Date:12/2/2009)... minutes of hospital arrival, study finds , ...onwide program to get faster treatment for people ...atically reduced the time between hospital arrival...quarters of people with STEMI heart attacks -- so ...at shows major blockage of a heart artery -- were ...
(Date:12/2/2009)... to come, NIH director says, , , WEDNES...l lines have been added to the pool that scientist...ore such lines will soon be made available, U.S. h...e the first additional embryonic stem cell lines a...nstitutes of Health (NIH) since President Barack O...
(Date:12/2/2009)...Represent Diverse Healthcare Stakeholders ,,... membership of the National Quality Forum (NQF) el...nd reappointed four current Board members. The new...e stakeholders, including consumers, providers, pu...ealthcare. ,, The newly elected Board members ...
(Date:12/2/2009)...Newswire/ -- TeamHealth ( www.teamhealth.com ) exp...quisition of Naples-based Emergency Physicians of ...ld an exclusive contract with NCH Healthcare Syste...n Naples Hospital, North Naples Hospital, and the ...ffing for two stand-alone urgent care clinics in N...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2
...ey brings more than 25 years of industry experienc...d (Nasdaq: MTEX ), a leading developer and provid... today announced the hiring of Marika,Berkley as t...ement team," said Terry O,Day, executive vice pres...
...r, race, schooling influence likelihood of giving ... (HealthDay News) -- Individual surgeon characteri...fluence whether a women receives radiation after b...rapy, even though it,s been shown to reduce breast...
...ence of major adverse events was also lower than r...9 (HealthDay News) -- In a large study comparing t...oated stents, Danish researchers found no overall ...ese flexible tubes implanted to help keep arteries...
...NGTON, Jan. 29 Answering President,Bush,s State o...n enactment,of bold solutions to reform the nation...n Health Care Association and National Center for ...,and post-acute care reform in the months ahead, w...
...This release is available in French . , , Resea...uncovered a previously unknown mechanism which cau...to sperm or ova -- to go through a period of "tran...ganism produces sterile offspring. , The study wa...
...ILLE, Tenn., Jan. 29 Healthcare Realty,Trust Inco...tock cash,dividend for the quarter ended December ...er share, is payable on March 3, 2008 to sharehold...-producing real estate,properties associated with ...
Other Medicine News:Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 2Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 3Health News:Surgeons' Characteristics Influence Breast Cancer Care 2Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3Health News:Answering Bush SOTU Retirement Reform Challenge, Long Term Care Profession Urges Congress to Enact Bold Reform of Long Term and Post Acute Care Delivery Systems 2Health News:Why your fertility cells must have 'radio silence' 2
(Date:12/2/2009)...PARK, Ill., Dec. 2 Abbot...ng a vast array of microorganisms has been named o...t magazine. A panel of expert judges evaluated a...mine the year,s top innovations, with the winners ...nline at www.the-scien t ist.com/top10innovati...
(Date:12/2/2009)...K, Dec. 2 With the addition of a M... by Neil H. Ekblom, LeClairRyan,s medical malpract... reach in the New York market. Mr. Ekblom, a forme...defending ophthalmology-related malpractice claims...p of medical malpractice defense attorneys located...
(Date:12/2/2009)...IAL, Colo., Dec. 2 AlloSource, one...kin, bone and soft tissue allografts for use in su...r of live cellular bone growth substitutes, today ... of hope as a float rider aboard the annual Donate...oses Parade®. Manuel Salazar, a 29-year-old ...
Breaking Medicine Technology:Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 3AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Chocolate Milks Natural Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink 47460 1Chocolate Milks Natural Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink 47460 2Chocolate Milks Natural Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink 47460 3National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 1National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 2National Museum of Dentistry Opens New Smile Experience Exhibition Recognizes Dr Irwin Smigel as Father of Aesthetic Dentistry 47455 3FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 1FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 2FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 3FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 4FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 5FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 6FDA Approves Labeling Change for VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII to Include Supplementary Clinical Data Supporting Efficacy at 13 12386 7
..., Mass., Jan. 15 Tolerx, Inc., a,biopharmaceutica... of novel,therapies for the treatment of immune-me...mpletion of a Phase Ib clinical study of TRX1, a n... in subjects with refractory,cutaneous lupus eryth...,assess the safety, tolerability, and pharmacokine...
...ubjects Now In Follow-up Period -, EXTON, Pa., Ja...day that injections have been completed in the piv...zed, placebo-controlled,clinical trials evaluating...olabial folds, or wrinkles (Studies IT-A-005 and I...period of the study., Isolagen also announced the...
Other Medicine Technology:Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 2Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 3Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies 2
FCY-15P2 - Slim Cystoscope
Shoelly Cystoscopes
Continuous Flow Cystoscopes
The Prostatron® System
Medicine Products: